EFC (I) Financial Statement Analysis
|
||
|
The Revenues of EFC (I) have increased by 56.57% YoY .
The Earnings Per Share (EPS) of EFC (I) has increased by 18.22 % YoY. |
||
EFC (I) Last 5 Annual Financial Results
[BOM: 512008|NSE : EFCIL]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Operating Income | ₹657 Cr | ₹419 Cr | ₹103 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Operating Expenses | ₹205 Cr | ₹91 Cr | ₹30 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Expenses | ₹329 Cr | ₹237 Cr | ₹48 Cr | ₹0.09 Cr | ₹0.09 Cr |
| Operating Profit (Excl OI) | ₹328 Cr | ₹183 Cr | ₹55 Cr | ₹-0.09 Cr | ₹-0.09 Cr |
| Other Income | ₹18 Cr | ₹9.32 Cr | ₹0.85 Cr | ₹0.11 Cr | ₹0.11 Cr |
| Interest | ₹46 Cr | ₹35 Cr | ₹15 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Depreciation | ₹100 Cr | ₹76 Cr | ₹34 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Profit Before Tax | ₹200 Cr | ₹81 Cr | ₹7.19 Cr | ₹0.02 Cr | ₹0.02 Cr |
| Profit After Tax | ₹141 Cr | ₹63 Cr | ₹3.86 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Consolidated Net Profit | ₹142 Cr | ₹58 Cr | ₹4.34 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Earnings Per Share (Rs) | ₹16.87 | ₹14.27 | ₹11.65 | ₹6.35 | ₹0.18 |
| PAT Margin (%) | 22.64 | 21.44 | 15.09 | 3.74 | 0.00 |
| ROE(%) | 34.03 | 28.19 | 25.47 | 10.73 | 0.76 |
| ROCE(%) | 37.93 | 36.31 | 34.56 | 32.82 | 1.17 |
| Total Debt/Equity(x) | 0.38 | 0.40 | 0.27 | 0.83 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 2,577.2 Cr |
| Revenue (TTM) | : | ₹ 1,099.9 Cr |
| Net Profit(TTM) | : | ₹ 258.8 Cr |
| EPS (TTM) | : | ₹ 17.5 |
| P/E (TTM) | : | 10.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| EFC (I) | -4.9% | -13.9% | -46.2% |
| SAGILITY | -6.9% | -7.8% | -2.7% |
| SYNGENE INTERNATIONAL | -3.5% | -8.7% | -41.6% |
| PRIME FOCUS | -5.6% | 7.8% | 61.3% |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | -2.5% | -4.5% | -11.8% |
| INDEGENE | 1.1% | 4.5% | 6.6% |
| NESCO | -4% | -1.3% | -26% |
| LATENT VIEW ANALYTICS | -7% | -16% | -40.7% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 1.4% | 0.6% | 45.5% |
EFC (I) Revenues
[BOM: 512008|NSE : EFCIL]
| Y-o-Y | 56.57 % |
| 5 Yr CAGR | 0 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹657 Cr | 56.57 | |
| Mar2025 | ₹419 Cr | 306.40 | |
| Mar2024 | ₹103 Cr | 0 | |
| Mar2023 | ₹0.00 Cr | 0 | |
| Mar2022 | ₹0.00 Cr | - | |
EFC (I) Operating Profit
[BOM: 512008|NSE : EFCIL]
| Y-o-Y | 79.45 % |
| 5 Yr CAGR | Positive |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹328 Cr | 79.45 | |
| Mar2025 | ₹183 Cr | 229.54 | |
| Mar2024 | ₹55 Cr | Positive | |
| Mar2023 | ₹-0.09 Cr | Negative | |
| Mar2022 | ₹-0.09 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 14.61 % |
| 5 Yr CAGR | 0 |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 49.89% | 14.61 | |
| Mar2025 | 43.53% | -18.92 | |
| Mar2024 | 53.69% | 0 | |
| Mar2023 | 0% | 0 | |
| Mar2022 | 0% | - | |
EFC (I) Profit After Tax
[BOM: 512008|NSE : EFCIL]
| Y-o-Y | 145.10 % |
| 5 Yr CAGR | 922.52 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹142 Cr | 145.10 | |
| Mar2025 | ₹58 Cr | 1,236.61 | |
| Mar2024 | ₹4.34 Cr | 33,269.23 | |
| Mar2023 | ₹0.01 Cr | 0.00 | |
| Mar2022 | ₹0.01 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 5.60 % |
| 5 Yr CAGR | 0 |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 22.64 % | 5.60 | |
| Mar2025 | 21.44 % | 42.08 | |
| Mar2024 | 15.09 % | 303.48 | |
| Mar2023 | 3.74 % | 0 | |
| Mar2022 | 0 % | - | |
EFC (I) Earnings Per Share (EPS)
[BOM: 512008|NSE : EFCIL]
| Y-o-Y | 18.22 % |
| 5 Yr CAGR | 211.14 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹17 | 18.22 | |
| Mar2025 | ₹14 | 22.49 | |
| Mar2024 | ₹12 | 83.46 | |
| Mar2023 | ₹6.35 | 3,427.78 | |
| Mar2022 | ₹0.18 | - | |
EFC (I) Return on Capital Employed (ROCE)
[BOM: 512008|NSE : EFCIL]
| Y-o-Y | 4.46 % |
| 5 Yr CAGR | 138.62 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 37.93% | 4.46 | |
| Mar2025 | 36.31% | 5.06 | |
| Mar2024 | 34.56% | 5.30 | |
| Mar2023 | 32.82% | 2,705.13 | |
| Mar2022 | 1.17% | - | |
EFC (I) Share Price vs Sensex
| Current Share Price | : | ₹174.3 |
| Current MarketCap | : | ₹ 2,577.2 Cr |
| Updated EOD on | : | Sep 29,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EFC (I) | -4.9% |
-13.9% |
-46.2% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
EFC (I) related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE SERVICES | -1.3% | -0.3% | 0.8% |
No NSE index found
You may also like the below Video Courses
FAQ about EFC (I) Financials
How the annual revenues of EFC (I) have changed ?
The Revenues of EFC (I) have increased by 56.57% YoY .
How the Earnings per Share (EPS) of EFC (I) have changed?
The Earnings Per Share (EPS) of EFC (I) has increased by 18.22 % YoY .
Check out Intrinsic Value of Peers of EFC (I)
Compare Stock Analytics of Peers of EFC (I)
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs
